Use of intravitreal steroids in the clinic

Plasma concentrations were obtained from 21 patients with macular edema due to branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO), and 21 patients with diabetic macular edema (DME) prior to dosing and at 4 to 5 additional post-dose timepoints on Days 1, 7, 21, 30, 45, 60, and 90 following the administration of the first intravitreal implant containing mg dexamethasone. In RVO and DME patients, the majority of plasma dexamethasone concentrations were below the lower limit of quantitation (LLOQ = 50 pg/mL). Plasma dexamethasone concentrations from 12% of samples were above the LLOQ, ranging from 52 pg/mL to 102 pg/mL. Plasma dexamethasone concentration did not appear to be related to age, body weight, or sex of patients.

Use of intravitreal steroids in the clinic

use of intravitreal steroids in the clinic

Media:

use of intravitreal steroids in the clinicuse of intravitreal steroids in the clinicuse of intravitreal steroids in the clinicuse of intravitreal steroids in the clinicuse of intravitreal steroids in the clinic

http://buy-steroids.org